Cargando…

CD30-targeted oncolytic viruses as novel therapeutic approach against classical Hodgkin lymphoma

Classical Hodgkin lymphoma (cHL) is a hematopoietic malignancy with a characteristic cellular composition. The tumor mass is made up of infiltrated lymphocytes and other cells of hematologic origin but only very few neoplastic cells that are mainly identified by the diagnostic marker CD30. While mos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanauer, Julia D.S., Rengstl, Benjamin, Kleinlützum, Dina, Reul, Johanna, Pfeiffer, Anett, Friedel, Thorsten, Schneider, Irene C., Newrzela, Sebastian, Hansmann, Martin-Leo, Buchholz, Christian J., Muik, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849188/ https://www.ncbi.nlm.nih.gov/pubmed/29560124 http://dx.doi.org/10.18632/oncotarget.24191

Ejemplares similares

On the origin of giant cells in Hodgkin lymphoma
por: Rengstl, Benjamin, et al.
Publicado: (2014)

Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most Effective
por: Kleinlützum, Dina, et al.
Publicado: (2017)

Small and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack consistent differences in gene expression profiles and are capable to reconstitute each other
por: Rengstl, Benjamin, et al.
Publicado: (2017)

Expression and Functional Relevance of Cannabinoid Receptor 1 in Hodgkin Lymphoma
por: Benz, Alexander H., et al.
Publicado: (2013)

A strong host response and lack of MYC expression are characteristic for diffuse large B cell lymphoma transformed from nodular lymphocyte predominant Hodgkin lymphoma
por: Schuhmacher, Bianca, et al.
Publicado: (2016)

Basal autophagy is pivotal for Hodgkin and Reed-Sternberg cells' survival and growth revealing a new strategy for Hodgkin lymphoma treatment
por: Birkenmeier, Katrin, et al.
Publicado: (2016)

Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte Rich Large B Cell Lymphoma - Endpoints of a Spectrum of One Disease?
por: Hartmann, Sylvia, et al.
Publicado: (2013)

Ectopic expression of transcription factor BATF3 induces B-cell lymphomas in a murine B-cell transplantation model
por: Weiser, Christian, et al.
Publicado: (2018)

The Tumor Suppressive mir-148a Is Epigenetically Inactivated in Classical Hodgkin Lymphoma
por: Paczkowska, Julia, et al.
Publicado: (2020)

3D image analysis reveals differences of CD30 positive cells and network formation in reactive and malignant human lymphoid tissue (classical Hodgkin Lymphoma)
por: Liebers, Julia, et al.
Publicado: (2019)

Rare Occurrence of Classical Hodgkin's Disease as a T Cell Lymphoma
por: Müschen, Markus, et al.
Publicado: (2000)

Immune phenotypes and checkpoint molecule expression of clonally expanded lymph node-infiltrating T cells in classical Hodgkin lymphoma
por: Ballhausen, Alexej, et al.
Publicado: (2022)

Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma
por: Wang, Yucai, et al.
Publicado: (2018)

Role of ADAM10 as a CD30 Sheddase in Classical Hodgkin Lymphoma
por: Hansen, Hinrich P., et al.
Publicado: (2020)

A case of gallstones in an African green monkey (Chlorocebus aethiops)
por: Kleinlützum, Dina, et al.
Publicado: (2017)

Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2/neu or EpCAM as target receptors
por: Hanauer, Jan RH, et al.
Publicado: (2016)

Identification of two unannotated miRNAs in classic Hodgkin lymphoma cell lines
por: Ustaszewski, Adam, et al.
Publicado: (2023)

Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors
por: Allen, Pamela B, et al.
Publicado: (2017)

CD19 and CD30 CAR T-Cell Immunotherapy for High-Risk Classical Hodgkin’s Lymphoma
por: Xue, YuanBo, et al.
Publicado: (2021)

Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP
por: Jachimowicz, Ron D., et al.
Publicado: (2021)

Genetics of classical Hodgkin Lymphoma
por: Schiavoni, Gianluca, et al.
Publicado: (2018)

Migration Properties Distinguish Tumor Cells of Classical Hodgkin Lymphoma from Anaplastic Large Cell Lymphoma Cells
por: Goncharova, Olga, et al.
Publicado: (2019)

Usefulness of BATF3 Immunohistochemistry in Diagnosing Classical Hodgkin Lymphoma
por: Benckendorff, Julian, et al.
Publicado: (2021)

P035: CRISPR/Cas9-mediated knockout reveals an important role of CD30 in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma
por: Kilian, Annika L., et al.
Publicado: (2022)

The molecular mechanisms of classic Hodgkin's lymphoma.
por: Felberbaum, Rachael S.
Publicado: (2005)

Immunological Deregulation in Classic Hodgkin Lymphoma
por: Romano, Alessandra, et al.
Publicado: (2014)

Controversies in the Treatment of Classical Hodgkin Lymphoma
por: Eichenauer, Dennis A., et al.
Publicado: (2018)

The Grey Zones of Classic Hodgkin Lymphoma
por: Bosch-Schips, Jan, et al.
Publicado: (2022)

P043: Molecular pathogenesis of Hodgkin lymphoma
por: Beeck, Lilian, et al.
Publicado: (2022)

Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy
por: Muik, Alexander, et al.
Publicado: (2012)

Deregulated miRNAs Contribute to Silencing of B-Cell Specific Transcription Factors and Activation of NF-κB in Classical Hodgkin Lymphoma
por: Paczkowska, Julia, et al.
Publicado: (2021)

T‐cell‐derived Hodgkin lymphoma has motility characteristics intermediate between Hodgkin and anaplastic large cell lymphoma
por: Bein, Julia, et al.
Publicado: (2022)

Mathematical Modeling of Oncogenesis Control in Mature T-Cell Populations
por: Gerdes, Sebastian, et al.
Publicado: (2013)

The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma
por: Dogan, Ahmet
Publicado: (2022)

CD30 induces Reed‐Sternberg cell‐like morphology and chromosomal instability in classic Hodgkin lymphoma cell lines
por: Watanabe, Mariko, et al.
Publicado: (2023)

Bob-1 is expressed in classic Hodgkin lymphoma
por: Abd El All, Howayda S
Publicado: (2007)

Resources-Stratified Guidelines for Classical Hodgkin Lymphoma
por: Relecom, Allan, et al.
Publicado: (2020)

MicroRNA signature in classical Hodgkin lymphoma
por: Paczkowska, Julia, et al.
Publicado: (2021)

Composite follicular lymphoma and classic Hodgkin lymphoma
por: Kim, Han-Na, et al.
Publicado: (2022)

Bone marrow involvement by classic Hodgkin lymphoma
por: Barouqa, Mohammad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ob1d1vhq8ivm1dds1055ltf407